Since there are so many current variants that I've restored the area plots.

Area plot of weekly hospital admissions by variant and log plot of each individual variant, US and New England, respectively.

#SARSCoV2 #Covid19 #USA #NewEngland

CDC Variant Proportions update:

A couple new entrants to the rave, but they've both been around for a long time without much growth: EU.1.1, FE.1.1, XBB.1.5.68

The combined XBB.1.9.x, XBB.1.16.x, and XBB.2.3 are dominant over XBB.1.5.x now.

Looks like the variants are finally causing an increase in hospitalizations, but it's small.

Plots are US and New England, linear and log scales, respectively.

#SARSCoV2 #COVID19 #USA #NewEngland

CovidActNow confirmed for me that case reporting is gone.

So I'm patching that using hospital admission data. It should be roughly in proportion with cases, so it should still work as an indicator of variant growth and decline.

Here are, as usual, the US and New England weekly hospital admissions by variant, linear and log scales, respectively.

#SARSCoV2 #Covid19 #USA #NewEngland

Belated CDC Variant Proportions update.

XBB.1.5.10 has been added; but it's been around at fairly static proportion for months now, so not much to worry about.

Even now, XBB.1.5 is still the single dominant variant and still declining, though the collective sum of XBB.1.9.x/XBB.1.16.x/XBB.2.3 are now dominant. No sharp increases despite this switchover.

Plots are US and New England, linear and log scale, by case count per variant.

#SarsCoV2 #Covid19 #USA #NewEngland

This week's CDC variant proportions update:

XBB.2.3 has been added to the mix this week. Growing as a proportion of cases but not as much as XBB.1.16 has been.

Again, it will be a while before XBB.1.16 becomes dominant. XBB.1.5 is falling faster than XBB.1.16 is growing.

Plots of cases by variant for US and New England, linear and log scales.

#SARSCoV2 #Covid #USA #NewEngland

CDC Variant Proportions update:

Plots of US and New England cases by variant, linear and log scale, respectively.

Nationally and in New England, cases are dropping overall while XBB.1.9.1 and XBB.1.16 climb - but they've slowed down, so it may be a while before they become dominant. If I had to guess, they may be a summer wave risk more than right now, based on current growth.

#SARSCoV2 #Covid #USA #NewEngland

CDC Variant Proportions update:

Nothing much new. XBB.1.5 still dominant, plateaued nationally but declining in New England.

XBB.1.9.1 rising quickly as a proportion, but based on a model and still a tiny amount of cases.

I should probably drop all the variants that didn't go much of anywhere to make these graphs more understandable.

US and New England, linear and log scales, respectively.

#SarsCoV2 #Covid19 #usa #NewEngland

US and New England cases by variant, linear and log scales, respectively.

Cases of XBB.1.5 still growing nationally - looks a lot like BA.2 did last spring. XBB.1.9.1 is rising quickly nationally. New England, still no clear signs yet, generally declining.

I switched to CovidActNow as the data source, but there are some clear differences with the JHU data. For example, JHU showed national cases growing recently; CAN shows a slight decrease.

#SARSCoV2 #Covid #USA #NewEngland

Weekly CDC Variant Proportions update:

Changed case data source from JHU, which has stopped collating this data, to NYT.

Still nothing much surprising. US overall plateaued, New England coming down.

Newcomer XBB.1.5.1 does seem to be outpacing its parent XBB.1.5 nationally, though not sharply.

#SarsCoV2 #Covid #USA #NewEngland

CDC Variant Proportions update.

Welcome to the class, XBB.1.5.1!

It's been slowly growing as a proportion of cases. Not particularly impressive growth on an absolute basis though.

US and New England, log and linear case plots by variant.

#SarsCoV2 #covid #USA #NewEngland

CDC Variant Proportions update

No surprises nationally or in New England. XBB.1.5 reigns, everything else going away.

Linear and log plots for US and New England, respectively,

#SarsCoV2 #Covid19 #USA #NewEngland

CDC Variant Proportions update:

Nothing surprising. XBB.1.5 continuing to take over. CH.1.1 mostly hanging around.

Nationally, cases slightly rising. But in New England, going down. In fact, it's the first time since the Omicron hydra appeared that we haven't had a new variant rising in the background. Might actually be a nice, safe spring and summer here?

Plots of cases by variant, linear and log scales, US and New England, respectively.

#SarsCoV2 #Covid19 #USA #NewEngland

CDC Variant Proportions update.

Nothing particularly surprising. XBB.1.5 continuing to take over, may drive a wave in some regions; CH.1.1 kind of hanging out at a low level; everything else fading away.

Plots are US and New England, linear and log scale by cases.

#SarsCoV2 #Covid #usa #NewEngland

From last week (delayed due to moving):

CDC variant proportions update

XBB.1.5 up again nationally, mostly in regions where it hasn't really hit yet for some reason. Even in New England it's plateaued at the moment rather than declining.

BA.5 is en route to extinction.

CH.1.1 is stagnating at a low level.

Plots are for the United States and New England, linear and log scales, by number of cases.

#USA #NewEngland #Massachusetts #SarsCoV2 #covid

CDC Variant Proportions update:

CH.1.1 has joined the party, *but* has actually been in the US for quite some time and has barely grown.

XBB.1.5 appears to still be reigning supreme.

Graphs are US and New England cases per variant, linear and log.

#SarsCoV2 #Covid #usa #NewEngland

Actually, now that XBB.1.5 is dominant, it's useful to see the linear single-variants plots again.

US and New England, respectively.

#SarsCoV2 #Covid #usa #NewEngland

CDC weekly variant proportions update for 1/27:

Nationally XBB.1.5 is still climbing, but it's faltering. Meanwhile every other variant appears to be declining everywhere.

National, and New England, area case plot and log scale cases.

#SarsCoV2 #Covid #usa #NewEngland

🎊 2023 starts with a significant milestone for the BioMed X Institute!

🤝 In #collaboration with AbbVie, @BioMed_X is launching its first #US project.

📌 The new BioMed X Institute will be located in New Haven, Connecticut.

🔬 Following a first joint #research project on Alzheimer’s disease at the BioMed X Institute in Heidelberg, Germany, the new US-based research collaboration will focus on #immunology & tissue engineering.

📰 Press Release: https://bio.mx/news/press-releases/biomed_x-and-abbvie-collaboration-us/

#NewEngland #BioMedX

@datasift3r I miss #NewEngland very much 😭

CDC weekly variant proportions update.

Not too much new to say. XBB.1.5 is dominating on the east coast, but the rest of the country still has BQ.1.x dominant.

Plots are US and New England, area plot of cases vs. log plot of each variant.

#SarsCoV2 #Covid #USA #NewEngland